Skip to main content
PMC home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2004 Oct 8;22(5):565–574. doi: 10.1002/ana.410220502

Molecular pathogenesis of neurotropic viral infections

F Gonzalez‐Scarano 1,✉, Kenneth L Tyler 2
PMCID: PMC7159691  PMID: 3322182

Abstract

Classical virologists defined a number of viruses that affect the nervous system and identified tissue tropism, extraneural replication, and viremia as important parameters that determine whether viral infections will affect the central nervous system. Molecular techniques are expanding this knowledge by permitting us to relate specific genes and gene products to two defined phenotypes: neuroinvasion and neurovirulence. Two converging situations make this knowledge particularly useful: (1) the development of antiviral drugs and subunit vaccines, which mandate that pathogenesis be related to specific regions of the viral genome; and (2) the expanding problem of central nervous system infections in immunodeficient states.

References

  • 1. Adachi A Gendelman HE Koeing S et al: Production of acquired immunodeficency syndrome associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59: 284–291, 1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Barre‐Sinoussi F, Chermann JC, Rey F, et al: Isolation of a Tlymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220: 868–871, 1983. [DOI] [PubMed] [Google Scholar]
  • 3. Bernoulli C Siegfried J Baumgartner G et al: Danger of accidental person‐to‐person transmission of Creutzfeldt‐Jakob disease by surgery. Lancer 1: 478–479, 1977. [DOI] [PubMed] [Google Scholar]
  • 4. Borsa J Sargent MD Copps TP et al: Specific monovalent cation effects on modification of reovirus infectivity by chymotrypsin digestion in vitro. J Virol 11: 1017–1019, 1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Cantin EM Puga A Notkins AL: Molecular biology of herpes simplex virus latency In Notkins AL, Oldstone MBA. (eds): Concepts in Viral Pathogenesis. New York: Springer‐Verlag, 1984, pp 172–177 [Google Scholar]
  • 6. Carroll SM, Higa HH, Paulson JC: Different cell‐surface receptor determinants of antigenically similar influenza virus hemagglutinins. J Biol Chem 256: 8357–8363, 1981. [PubMed] [Google Scholar]
  • 7. Cavanagh D, Sangar DB, Rowlands DJ, Brown F: Immunogenic and cell attachment sites of FMDV: further evidence for their location in a single capsid polypeptide. J Gen Virol 35: 149–158, 1977. [DOI] [PubMed] [Google Scholar]
  • 8. Chuke W‐F, Walker DL, Peitzman LB, Frisque RJ: Construction and characterization of hybrid polomavirus genomes. J Virol 60: 960–971, 1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Co MS, Gaulton GN, Fields BN, Greene MI: Isolation and biochemical characterization of the mammalian reovirus type 3 cell‐surface receptor. Proc Natl Acad Sci USA 82: 1494–1498, 1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Co MS Gaulton GN Tominaga A et al: Structural similarities between the mammalian β‐adrenergic and reovirus type 3 receptors. Proc Natl Acad Sci USA 82: 5315–5318, 1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Colonno RJ Callahan PL Long WL: Isolation of a monoclonal antibody that blocks attachment of the major group of human rhinoviruses. J Virol 57: 7–12, 1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Cook ML Stevens JG: Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra‐axonal transport of infection. Infect Immun 7: 272–288, 1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Coulon P, Rollin P, Aubert M, Flamand A: Molecular basis of rabies virus virulence I. Selection of avirulent mutants of the CVS strain with anti‐G monoclonal antibodies. J Gen Virol 61: 97–100, 1982. [DOI] [PubMed] [Google Scholar]
  • 14. Coulon P Rollin P Flamand A: Molecular basis of rabies virus virulence II. Identification of a site on the CVS glycoprotein associated with virulence. J Gen Virol 64: 693–696, 1983. [DOI] [PubMed] [Google Scholar]
  • 15. Dietzchold B Wiktor TJ Trojanowski JQ et al: Differences in cell‐to‐cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro . J Virol 56: 12–18, 1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Dietzschold B Wunner WJ Wiktor TJ et al: Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci USA 80: 70–74, 1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Drayna D Fields BN: Genetic studies of the reovirus transcriptase: genetic analysis. J Gen Virol 63: 149–159, 1982. [DOI] [PubMed] [Google Scholar]
  • 18. Drayna D Fields BN: Biochemical studies on the mechanism of chemical and physical inactivation of reovirus. J Gen Virol 63: 161, 1982. [DOI] [PubMed] [Google Scholar]
  • 19. Feinerg MB Jarret RF Aldovini A et al: HTLV III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell 46: 807–817, 1986. [DOI] [PubMed] [Google Scholar]
  • 20. Garten W Bosch FX Linder D et al: Proteolytic activation of the influenza virus hemagglutinin: the structure of the cleavage site and the enzymes involved in cleavage. Virology 115: 361–374, 1981. [DOI] [PubMed] [Google Scholar]
  • 21. Gentsch JR Pacitti AF: Effect of neuraminidase treatment of cells and effect of soluble glycoproteins on type 3 reovirus attachment to murine L cells. J Virol 56: 356–364, 1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Gerhard W, Yewdell J, Frankel ME, Webster R: Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 290: 713–717, 1981. [DOI] [PubMed] [Google Scholar]
  • 23. Gething MJ White JM Waterfield MD: Purification of the fusion protein of Sendai virus: analysis of the NH2 terminal sequence generated during precursor activation. Proc Natl Acad Sci USA 75: 2737–2740, 1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Gilden D Vafai A Devlin M et al: Detection of varicella‐zoster virus nucleic acid in human thoracic ganglia and leukocytes. Neurology 36(suppl 1):202, 1986. [DOI] [PubMed] [Google Scholar]
  • 25. Goldstein JL Anderson RGW Brown MS: Coated pits, coated vesicles, and receptor mediated endocytosis. Nature 21: 679–685, 1979. [DOI] [PubMed] [Google Scholar]
  • 26. Gonzalez‐Scarano F, Janssen RS, Najjar JA, et al: An avirulent G 1 glycoprotein variant of La Crosse bunyavirus with defective fusion function. J Virol 54: 757–763, 1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Green M: Transformation and oncogenesis: DNA viruses In Fields BN, et al (eds): Virology. New York: Raven, 1985, pp 183–234 [Google Scholar]
  • 28. Haase AT: Pathogenesis of lentivirus infections. Nature 322: 130–136, 1986. [DOI] [PubMed] [Google Scholar]
  • 29. Hood L Kronenbeg M Hunkapiller T: T cell antigen receptors and the immunoglobulin supergene family. Cell 40: 225–229, 1984. [DOI] [PubMed] [Google Scholar]
  • 30. Janssen RS, Gonzalez‐Scarano F, Nathanson N: Mechanisms of bunyavirus virulence. Lab Invest 50: 447–455, 1984. [PubMed] [Google Scholar]
  • 31. Janssen RS, Nathanson N, Endres MJ, Gonzalez‐Scarano F: Virulence of La Crosse is under polygenic control. J Virol 59: 1–7, 1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Johnson RT: Viral Infections of the Nervous System. New York: Raven, 1982. [Google Scholar]
  • 33. Joklik WK: Studies on the effect of chymotrypsin on reovirions. Virology 49: 700, 1972. [DOI] [PubMed] [Google Scholar]
  • 34. Kaye KM, Spriggs DR, Bassel‐Duby R, et al: Genetic basis for altered pathogenesis of an immune‐selected antigenic variant of reovirus type 3 (Dearing). J Virol 59: 90–97, 1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Keller J Alwine JC: Activation of SV‐40 latent promotor: direct effects of T antigen in the absence of viral DNA replication. Cell 36: 381–389, 1984. [DOI] [PubMed] [Google Scholar]
  • 36. Kenney S Natarayan V Strike D et al: JC virus enhancer‐promoter active in human brain cells. Science 226: 1337–1339, 1984. [DOI] [PubMed] [Google Scholar]
  • 37. Koenig S Gendelman HE Orenstein JM et al: Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233: 1089–1093 [DOI] [PubMed] [Google Scholar]
  • 38. Khoury G Gruss P: Enhancer elements. Cell 33: 313–314, 1983. [DOI] [PubMed] [Google Scholar]
  • 39. Kohler G Milstein C: Continuous cultures of fused cells secreting antibodies of predetermined specificity. Nature 256: 495–497, 1975. [DOI] [PubMed] [Google Scholar]
  • 40. Laimins LA Khoury G Gorman C et al: Host specific activation of transcription by tandem repeats from simian virus 40 and Moloney sarcoma virus. Proc Natl Acad Sci USA 79: 6453–6457, 1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Lazarowitz SG Choppin PW: Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypetide. Virology 68: 440–454, 1975. [DOI] [PubMed] [Google Scholar]
  • 42. Lenard J Miller DK: Uncoating of enveloped viruses. Cell 28: 5–6, 1982. [DOI] [PubMed] [Google Scholar]
  • 43. Lentz TL Burrage TG Smith AL et al: Is the acetylcholine receptor a rabies virus receptor? Science 215: 182–184, 1982. [DOI] [PubMed] [Google Scholar]
  • 44. Lowly DR: Transformation and oncogenesis: retroviruses In Fields BN, et al: Virology. New York: Raven, 1985, pp 235–263 [Google Scholar]
  • 45. Maizel JV Phillips BA Summers DF: Composition of artificially produced and naturally occurring empty capsids of poliovirus type I. Virology 32: 692–699, 1967. [DOI] [PubMed] [Google Scholar]
  • 46. Mellman I Fuchs R Helenius A: Acidification of the endocytic and exocytic pathways. Ann Rev Biochem 55: 663–700, 1986. [DOI] [PubMed] [Google Scholar]
  • 47. Minor PD Pipkin PA Hockley D et al: Monoclonal antibodies which block cellular receptors of poliovirus. Virus Res 1: 203–212, 1984. [DOI] [PubMed] [Google Scholar]
  • 48. Monath TP Cropp CB Harrison AK: Mode of entry of a neurotropic arbovirus into the central nervous system. Lab Invest 48: 399–410, 1983. [PubMed] [Google Scholar]
  • 49. Muggeridge M Fraser NW: Chromosomal organization of the herpes simplex virus genome during acute infection of the mouse central nervous system. J Virol 59: 764–767, 1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Murphy FA: Rabies pathogenesis: brief review. Arch Virol 54: 279–297, 1977. [DOI] [PubMed] [Google Scholar]
  • 51. Murphy FA Bauer SP: Early street rabies virus infection in striated muscle and later progression to the central nervous system. Intervirology 3: 256–268, 1974. [DOI] [PubMed] [Google Scholar]
  • 52. Nathanson N: Pathogenesis In Monath TP. (ed): St. Louis Encephalitis. Washington, DC: American Public Health Association, 1980, pp 201–236 [Google Scholar]
  • 53. Notkins AL Onodera T Prabhakar BS: Virus induced autoimmunity In Notkins AL, Oldstone MBA. (eds): Concepts in Viral Pathogenesis. New York: Springer‐Verlag, 1984, pp 210–216 [Google Scholar]
  • 54. Notkins AL Oldstone MBA: Concepts in Viral Pathogensis. New York: Springer‐Verlag, 1984. [Google Scholar]
  • 55. Oakes JE Gray WL Lausch RN: HSV‐1 DNA sequences which direct spread of virus from cornea to CNS. Virology 150: 513–517, 1986. [DOI] [PubMed] [Google Scholar]
  • 56. Oldstone MBA, Rodriguez M, Daughaday WH, Lampert PW: Viral perturbation of endocrine function: disordered cell function leads to disturbed homeostasis and disease. Nature 307: 278–281, 1984. [DOI] [PubMed] [Google Scholar]
  • 57. Patterson JL Holloway B Kolakofsky D: La Crosse virions contain a primer‐stimulated RNA polymerase and a methylated cap‐dependent endonuclease. J Virol 52: 215–222, 1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Philipson L: The early interaction of animal viruses and cells. Prog Med Virol 5: 43–78, 1963. [PubMed] [Google Scholar]
  • 59. Plotch SJ, Bouloy M, Ulmanen I, Krug RM: A unique cap (7mGpppXM) dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell 23: 847–858, 1981. [DOI] [PubMed] [Google Scholar]
  • 60. Popovic M, Sarngadharan MG, Read E, Gallo RC: Detection, isolation, and continuous production of cytopathic retroviruses (HTLV III) from patients with AIDS and pre‐AIDS. Science 224: 497–500, 1984. [DOI] [PubMed] [Google Scholar]
  • 61. Preston CM Tannahil D: Effects of orientation and position on the activity of herpes simplex virus immediate early gene farupstream region. Virology 137: 439–444, 1984. [DOI] [PubMed] [Google Scholar]
  • 62. Riviere Y Oldstone MBA: Genetic reassortants of lymphocytic choriomeningitis virus: unexpected disease and mechanism of pathogenesis. J Virol 59: 363–368, 1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Rock DL Fraser NW: Detection of HSV‐1 genome in central nervous system of latently infected mice. Nature 302: 523–525, 1983. [DOI] [PubMed] [Google Scholar]
  • 64. Rogers GN Paulson JC Daniels RS et al: Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature 304: 76–78, 1983. [DOI] [PubMed] [Google Scholar]
  • 65. Rossman MG Arnold E Erickson JW et al: Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317: 145–153, 1985. [DOI] [PubMed] [Google Scholar]
  • 66. Rubin DH Fields BN: Molecular basis of reovirus virulence: role of the M2 gene. J Exp Med 152: 853–868, 1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Scheid A Choppin PW: Proteolytic cleavage and viral pathogenesis In Notkins AL, Oldsone MB. (eds): Concepts in Viral Pathogenesis. New York: Springer‐Verlag, 1984, pp 26–31 [Google Scholar]
  • 68. Skehel JJ Bayley PM Brown EB et al: Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus‐mediated membrane fusion. Proc Natl Acad Sci USA 79: 968–972, 1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Smith EM, Estes MK, Graham DY, Gerba CP: A plaque assay for the simian rotavirus SA11. J Gen Virol 43: 513–519, 1979. [DOI] [PubMed] [Google Scholar]
  • 70. Sodroski JG, Rosen C, Wong‐Staal F, et al: Trans‐acting transcriptional regulation of human T‐cell leukemia virus type III long terminal repeat. Science 227: 171–173, 1985. [DOI] [PubMed] [Google Scholar]
  • 71. Spriggs DR Bronson RT Fields BN: Hemagglutinin variants of reovirus type 3 have altered central nervous system tropism. Science 220: 505–507, 1983. [DOI] [PubMed] [Google Scholar]
  • 72. Springgs DR Fields BN: Attenuated reovirus type 3 strains generated by selection of hemagglutinin antigenic variants. Nature 297: 68–70, 1982. [DOI] [PubMed] [Google Scholar]
  • 73. Stott EF Killington RA: Rhinoviruses. Annu Rev Microbiol 25: 503–524, 1972. [DOI] [PubMed] [Google Scholar]
  • 74. Suzumura A, Lavi E, Weiss SR, Silberberg DH: Coronavirus infection induces H‐2 antigen expression on oligodendrocytes and astrocytes. Science 232: 991–993, 1986. [DOI] [PubMed] [Google Scholar]
  • 75. Tyler KL McPhee DA Fields BN: Distinct pathway of viral spread in the host determined by reovirus S1 gene segment. Science 233: 770–774, 1986. [DOI] [PubMed] [Google Scholar]
  • 76. Wiley DC Wilson IA Skehel JJ: Structural identification of the antibody‐binding sites of Hong‐Kong influenza hemagglutinin and their involvement in antigenic variation. Nature 289: 373–378, 1981. [DOI] [PubMed] [Google Scholar]
  • 77. Wilson IA Skehel JJ Wiley DC: Structure of the hemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 289: 366–373, 1981. [DOI] [PubMed] [Google Scholar]
  • 78. Wolinsky JS Stroop WG: Virulence and persistence of three prototype strains of mumps virus in newborn hamsters. Arch Virol 57: 355–359, 1978. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Neurology are provided here courtesy of Wiley

RESOURCES